900000000000489007: Concept inactivation indicator attribute value reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Attribute value type\Concept inactivation indicator reference set

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Concept inactivation indicator reference set	Is a	Attribute value type	true	Inferred relationship	Some

Members	valueId
Adverse reaction to other mineral salts NEC	Limited component (foundation metadata concept)
Adverse reaction to other muscle drugs	A component that fails to comply with the current editorial guidance.
Adverse reaction to other non-narcotic analgesics	Limited component (foundation metadata concept)
Adverse reaction to other opiates and related narcotics	Classification derived component
Adverse reaction to other opiates and related narcotics	Classification derived component
Adverse reaction to other psychotropic agent	A component that fails to comply with the current editorial guidance.
Adverse reaction to other respiratory system drugs	A component that fails to comply with the current editorial guidance.
Adverse reaction to other sedatives and hypnotics	Limited component (foundation metadata concept)
Adverse reaction to other sedatives and hypnotics NOS	Limited component (foundation metadata concept)
Adverse reaction to other skin, mucous membrane, ophthalmological, otorhinolaryngological and dental drugs	A component that fails to comply with the current editorial guidance.
Adverse reaction to other tranquilizers (disorder)	Limited component (foundation metadata concept)
Adverse reaction to other vaccines and biological substances	Limited component (foundation metadata concept)
Adverse reaction to other vasodilators	Limited component (foundation metadata concept)
Adverse reaction to other viral and rickettsial vaccines	Limited component (foundation metadata concept)
Adverse reaction to ovarian hormone or synthetic substitute NOS	Limited component (foundation metadata concept)
Adverse reaction to ovarian hormones and synthetic substitutes	Ambiguous
Adverse reaction to oxazepam	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to oxazolidine derivatives NOS	Limited component (foundation metadata concept)
Adverse reaction to oxitropium	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to oxprenolol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to oxypertine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to oxytetracycline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to oxytocic agent NOS	Limited component (foundation metadata concept)
Adverse reaction to oxytocin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to papaverine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to paracetamol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to paracetamol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to paraldehyde	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to parasympatholytic or spasmolytic NOS	Ambiguous
Adverse reaction to parasympathomimetic	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to parasympathomimetics NOS	Limited component (foundation metadata concept)
Adverse reaction to parathyroid and parathyroid derivatives NOS	Ambiguous
Adverse reaction to parathyroid hormone agent	Ambiguous
Adverse reaction to pemoline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to penicillamine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to penicillin NOS	Limited component (foundation metadata concept)
Adverse reaction to penicillins	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to penicillins	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pentaerythritol tetranitrate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pentamidine isethionate	Ambiguous
Adverse reaction to pentazocine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pericyazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to perphenazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pertussis vaccine, including combinations with a pertussis component	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pethidine hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pharmaceutical excipients	Ambiguous
Adverse reaction to phenelzine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to phenindione	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to phenobarbitone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to phenothiazine-based tranquilizer (finding)	Ambiguous
Adverse reaction to phenothiazine-based tranquilizers NOS (disorder)	Limited component (foundation metadata concept)
Adverse reaction to phenoxybenzamine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to phentolamine mesylate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to phenytoin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to phyenylbytazone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pilocarpine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to piperacillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to piperazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to piperazine estrone sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pivampicillin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pivmecillinam	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to plicamycin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to poliomyelitis vaccine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to poliomyelitis vaccine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to polymyxin B sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to polythiazide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to posterior pituitary hormone NOS	Limited component (foundation metadata concept)
Adverse reaction to practolol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pravastatin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to prazosin	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to prednisolone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to prednisone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to prenylamine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to prilocaine hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to primaquine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to primidone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to probenecid	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to procainamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to procaine hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to procarbazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to prochlorperazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to progesterone	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to proguanil hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to promazine	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to promethazine hydrochloride	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to propofol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to propranolol	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to propylthiouracil	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to prostaglandins	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to protamine sulfate	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to proton pump inhibitors	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to protriptyline	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to psychostimulant	Ambiguous
Adverse reaction to psychostimulant NOS	Limited component (foundation metadata concept)
Adverse reaction to psychotropic agent	A component that fails to comply with the current editorial guidance.
Adverse reaction to psychotropic agent NOS	Classification derived component
Adverse reaction to purine derivative diuretic NOS	Limited component (foundation metadata concept)
Adverse reaction to pyrantel	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pyrazinamide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.
Adverse reaction to pyrazole derivatives NOS	Limited component (foundation metadata concept)
Adverse reaction to pyridostigmine bromide	A component has been made inactive because it duplicates another component of the same type. E.g. A description that duplicates another description or a concept that duplicates another concept.

Start Previous Page 81 of 1411 Next End

Reference Sets

Reference set descriptor

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001066017	Concept inactivation indicator attribute value reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001067014	Concept inactivation indicator reference set	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001068016	Concept inactivation indicator attribute value reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)